Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Praluent
Praluent
No early success for Regeneron, Sanofi in PhIII outcomes study for PCSK9 drug Praluent
Endpoints
Thu, 11/17/16 - 09:54 am
Regeneron
Sanofi
Praluent
PCSK9 inhibitors
These pricey cholesterol drugs aren’t selling. And that has the biotech industry sweating
Stat
Fri, 10/28/16 - 10:07 am
PCSK9 inhibitors
Amgen
Regeneron
Sanofi
Repatha
Praluent
statins
Amgen, Sanofi and Regeneron trot out new PCSK9 data at European heart meeting
Fierce Pharma
Mon, 08/29/16 - 05:52 pm
Amgen
Sanofi
Regeneron
PCSK9 inhibitors
Repatha
Praluent
These Next-Generation Cholesterol Drugs Could Raise U.S. Healthcare Costs by $119 Billion a Year
Motley Fool
Sun, 08/28/16 - 10:07 am
PCSK9 inhibitors
Amgen
Repatha
Regeneron
Praluent
Sanofi
Are PCSK9 meds worth the cost? Only if Amgen, Sanofi and Regeneron slash prices by two-thirds: JAMA
Fierce Pharma
Wed, 08/17/16 - 12:11 pm
PCSK9 inhibitors
Amgen
Sanofi
Regeneron
Praluent
Repatha
JAMA
drug pricing
Amgen, Sanofi Cholesterol Drugs Not Cost-Effective, Study Says
Bloomberg
Tue, 08/16/16 - 04:34 pm
Amgen
Sanofi
Regeneron
Praluent
Repatha
Pfizer, Amgen, Regeneron Pharmaceuticals: How the PCSK9 Market is Evolving
Bidness, ETC
Thu, 07/7/16 - 03:41 pm
Pfizer
Amgen
Regeneron
PCSK9 inhibitors
Repatha
Praluent
Regeneron and Sanofi Announce Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia in Japan
Yahoo
Tue, 07/5/16 - 10:10 am
Regeneron
Sanofi
Praluent
Japan
PCSK9 inhibitors
3 Potential Stock-Moving Drug Events In The Second Half Of 2016
Investors.com
Fri, 07/1/16 - 10:07 am
Eli Lilly
solanezumab
Alzheimer's disease
Gilead Sciences
hepatitis C
Sovaldi
Harvoni
Epclusa
Sanofi
Regeneron
Praluent
Regeneron Pharmaceuticals Inc: Eylea and Praluent Sales Growth Under Risk
Bidness, ETC
Sat, 06/18/16 - 02:21 pm
Regeneron
Eyelea
Praluent
Amgen, Inc. can Force Praluent Off Market but Regeneron Pharmaceuticals Inc May Still Be OK
Bidness, ETC
Thu, 06/16/16 - 03:22 pm
Amgen
Sanofi
Regeneron
Praluent
Repatha
patents
PCSK9 inhibitors
Sanofi, Amgen cholesterol drugs win UK backing after price cuts
Yahoo/Reuters
Fri, 05/6/16 - 10:47 am
Sanofi
Amgen
UK
PCSK9 inhibitors
Repatha
Praluent
New heart drugs struggle to win sales as doctors hold back
Yahoo/Reuters
Thu, 04/21/16 - 09:16 am
Novartis
Entresto
Sanofi
Amgen
Praluent
Repatha
physicians
Why one analyst thinks a Sanofi and Regeneron cholesterol drug will be yanked
Stat
Wed, 03/23/16 - 09:36 pm
Sanofi
Regeneron
Praluent
PCKS9 inhibitors
Amgen's PCSK9 patent win 'reasonably likely' to push Sanofi's Praluent off the market: Analyst
Fierce Pharma
Tue, 03/22/16 - 04:12 pm
Amgen
patents
Sanofi
PCSK9 inhibitors
Regeneron
Repatha
Praluent
Regeneron, Sanofi Strongly Disagree to Jury’s Verdict in Amgen Patent Trial
Bidness, ETC
Wed, 03/16/16 - 07:22 pm
Sanofi
Regeneron
Amgen
patents
PCSK9
Repatha
Praluent
Amgen Ahead of Regeneron; Controlling 60% of PCSK-9 Market
Bidness, ETC
Wed, 02/17/16 - 10:46 am
Amgen
Regeneron
Sanofi
PCSK9 inhibitors
Repatha
Praluent
Express Scripts sees slow 2016 sales for new cholesterol drugs
Yahoo/Reuters
Fri, 02/12/16 - 04:15 pm
Express Scripts
PCSK9 inhibitors
Amgen
Regeneron
Sanofi
Repatha
Praluent
Big Pharma's new PCSK9, heart failure meds stuck in the slow lane. What gives?
Fierce Pharma Marketing
Wed, 02/10/16 - 03:20 pm
PCSK9 inhibitors
heart failure
Praluent
Repatha
Novartis
Amgen
Sanofi
Regeneron
Amgen Is Now Strides Ahead of Regeneron in the PCSK9 Race
Bidness, ETC
Tue, 02/9/16 - 04:26 pm
Amgen
Regeneron
PCSK9 inhibitors
Praluent
Repatha
Pages
« first
‹ previous
1
2
3
4
5
6
next ›
last »